SCHEMBL3479645

SCHEMBL3479645

CN1CCN(c2ccccc2F)c2ccc(N3CCNCC3)cc2C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 4/20 0.41
HTR3E A5X5Y0 2/20 0.41
HTR3B O95264 2/20 0.41
HTR3D Q70Z44 2/20 0.41
HTR3C Q8WXA8 2/20 0.41
SIGMAR1 Q99720 2/20 0.41
HTR5A P47898 1/20 0.41
HTR6 P50406 6/20 0.41
DRD3 P35462 2/20 0.41
ADRB1 P08588 4/20 0.39
HTR2C P28335 1/20 0.38
TGFBR1 P36897 1/20 0.38
ACVR1 Q04771 1/20 0.38
HTR1A P08908 3/20 0.37
HTR7 P34969 3/20 0.37
KDM4E B2RXH2 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479772 0.92 HTR3A (0.46) HTR3AHTR6DRD3KDM4EGAA
SCHEMBL3479608 0.88 ALDH1A1 (0.42) HTR3AHTR6DRD3ADRB1TGFBR1
SCHEMBL3226172 0.86 SLC6A2 (0.44) HTR3ASIGMAR1KDM4EGAAMAPT
SCHEMBL3239201 0.85 ADRB1 (0.47) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL3479783 0.85 ADRB1 (0.40) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL3479410 0.84 HTR1A (0.45) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL3479564 0.83 ADRB1 (0.40) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL3232992 0.82 RORC (0.45) SIGMAR1HTR6HTR2CHTR1AMAPT
SCHEMBL3231453 0.81 HSD17B10 (0.56) SIGMAR1HTR6DRD3KDM4EMAPK1
SCHEMBL3224500 0.80 SLC6A2 (0.48) HTR3AHTR3EHTR3BHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D HTR3A 30/4885HTR3E 42/4885HTR3B 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.